CellMax Garners $14,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1271 Oakmead Parkway Sunnyvale, CA 94085 USA
  • Company Description
    CellMax Assure helps your patients understand and manage their hereditary risk for cancer. Offering a broad menu of testing options and access to a personalized risk management program, CellMax Assure enables you to support your patients with easy, convenient cancer risk testing.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The new $9M in funding is being used for continued product development, ongoing clinical trials, and commercialization of the full range of blood tests, including genetic cancer risk detection, and early cancer detection for colorectal and other cancers.
  • M&A Terms
  • Venture Investor
    Artiman Ventures
  • Venture Investor
  • Venture Investor

Trending on Xconomy